Summarized by / Author: Rohini Manaktala MD (1), Rooma Nankani MD (1) Summary Reviewer: Paul Robert Anthony Jr. MD (2) Contribution To Literature: This trial revealed the beneficial outcome of treating early gastric cancer with H.pylori eradication therapy and the reduction in future development of metachronous gastric cancer compared to placebo. Description: The goal of the trial..
Category: Infectious Disease - page 3
Procalcitonin has proven to be a great marker for guiding antibiotics treatment in patients with concern for lower respiratory tract infections. However, it’s not yet established how much does clinicians adhere to using the antibiotic therapy based on procalcitonin results. The ProACT trial recently got published in NEJM. It showed that despite it’s usefulness, clinicians..
The APROCCHSS trial clinically analyze the combination of steroid therapy in patients with septic shock and shows significant mortality benefit. Source: NEJM
Source: The LANCET